MRI Contrast Media

Image: medical scientist with patient, MRI
Following the development of magnetic resonance imaging in 1978, specialists have been able to look into the human brain for very the first time. Subsequent developments have also enabled them to create images that show the difference between malign tumors and healthy tissue.

We launched the first contrast medium for magnetic resonance imaging in 1988, setting a further milestone in the development of contrast media.

The special characteristics of the first MRI contrast medium were improved contrast and extended application possibilities. By 2006, it had been successfully used over 70 million times and helped to make Bayer HealthCare Pharmaceuticals the world market leader in MRI contrast media.

New insights with new technologies

More recent developments in MRI contrast media include a substance for examinations that require a high concentration of contrast media – such as an MRI of the brain or for visualizing the blood flows in tumors. They also include an organ-specific contrast medium which allows an exact diagnosis of even small lesions of the liver. This contrast medium is absorbed specifically by liver cells and therefore enhances contrast in healthy liver tissue. Any pathological changes of the organ caused by tumors, metastases or other malignant or benign lesions that exhibit little or no liver-cell function can be detected, located and characterized in this way.

Raw data generated by the scanner and MRI scans without and with contrast

Diagnostic Imaging

Click here for more information about this topic.

Page tools
.
Annual Report 2012

open
close
http://www.bayerpharma.com/en/therapeutic-areas/imaging-techniques/mri-contrast-media/index.php

Copyright © Bayer Pharma AG